Your current location:HomeNewsNews

Good news! Emerson was recognized as a national high-tech enterprise in 2020!

According to the relevant regulations of the Ministry of Science and Technology of the People's Republic of China on the Administration of Recognition of High-tech Enterprises (Guoke Fahuo [2016] No. 32) and the Guidelines for the Management of High-tech Enterprise Recognition (Guoke Fahuo [2016] No. 195), Wuhan Emerson Life With its professional R&D team, excellent technical strength, continuous innovation ability and scientific enterprise management, Technology Co., Ltd. has successfully passed the certification of high-tech enterprises.


The identification of high-tech enterprises adopts the centralized evaluation of the province's enterprises online. There are many enterprises that have been rejected by one vote. It is also increasingly difficult for enterprises to pass the evaluation. After preliminary research, audit evaluation, reporting of materials and other necessary links, as well as layers of screening by the state and relevant accreditation agencies, Emerson obtained the high-tech enterprise qualification in December 2020 and obtained the 'High-tech Enterprise Certificate'.

喜报!艾米森获2020年国家高新技术企业认定!


Improve the core competitiveness of enterprises


In recent years, Emerson has continued to carry out research and development and transformation of technological achievements, and has the core independent intellectual property rights of the enterprise. Since its establishment, the company has adhered to independent research and development, focused on scientific and technological innovation and talent team building, insisted on centering on the needs of diagnosis and treatment, and striving for innovators as the foundation, and continued to forge ahead. Now it has developed into a scientific and technological innovation enterprise integrating independent research and development, production and sales. With the product concept of 'early stage, precision, non-invasive and convenient', the company is committed to building the world's leading tumor screening technology platform! On the one hand, the identification of high-tech enterprises will effectively improve the enterprise's innovation awareness and management level, improve the core competitiveness of the enterprise, and significantly enhance the company's brand influence; on the other hand, high-tech enterprises have priority to declare policy dividends such as government project support funds The government will also give priority support to the scientific and technological research and development activities of enterprises.

喜报!艾米森获2020年国家高新技术企业认定!

Build a technologically innovative enterprise


Wuhan Emerson is a new type of tumor early screening enterprise with independent intellectual property rights and core technology advantages. The product line mainly focuses on the early detection and development of global high-incidence malignant tumors. In recent years, Wuhan Emerson has focused on the accurate detection of early colorectal cancer and precancerous lesions. The self-developed Aichangkang colorectal cancer early screening kit has excellent performance in clinical and market applications. The company has applied for more than 30 patents and many PCT patents; it has obtained 4 authorized invention patents and more than 10 authorized utility model patents. It has a number of mature product lines for early tumor screening, including 'Ai Changkang', 'Ai Gongshu', 'Ai Gongle', and 'Aisining'. The company has won the honorary titles of Optics Valley 3551 Entrepreneurial Talents, Optics Valley 3551 (Long-term) Innovative Talents, Yellow Crane Talents, Hubei Young Talents, Nanjing 321 Talents and other honorary titles. He has emerged in major biomedical competitions across the country, and won the Outstanding Enterprise Award in the Biomedical Finals of the China Innovation and Entrepreneurship Competition, the Bronze Award of the China Youth Innovation and Entrepreneurship Competition, the Golden Wing Award of China Creation Wing, the second prize of the China Medical Device Innovation and Entrepreneurship Competition, and the China Innovation and Entrepreneurship Competition. Entrepreneurship Competition (Hubei) Biomedical Final Champion, Shenzhen Nanshan Entrepreneurship Star Biomedical and Industry-wide Champion, Entrepreneurship Hubei Champion, Deloitte Optics Valley Rising Star and other honors.


share:

Related suggestion